# Pharmacogenetics of Liver Toxicity in Patients With Multiple Sclerosis Treated With Fingolimod

> **NCT05516303** · — · UNKNOWN · sponsor: **University Hospital, Caen** · enrollment: 65 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **GENETIC:** Genetic polymorphism
- **DIAGNOSTIC_TEST:** Measurement of fingolimod and fingolimod-phosphate concentrations

## Key facts

- **NCT ID:** NCT05516303
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-07
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05516303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05516303, "Pharmacogenetics of Liver Toxicity in Patients With Multiple Sclerosis Treated With Fingolimod". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05516303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*